Hepatological risk in the treatment of overweight and obesity: possible ways of prevention

Authors: V.P. Shipulin, MD, National Medical Academy of Postgraduate Education named after N.N. P.L. shupika,

V.V. Chernyavsky, Ph.D., National Medical University. A.A. Bogomolets, Kyiv


According to WHO experts, the prevalence of overweight and obesity in the global population has become epidemic.

The increase in the incidence of obesity among young people and children suggests that the situation will worsen. Unfortunately, in Ukraine there are no reliable scientific statistics on overweight and obese people. However, every practitioner will confirm that this problem is no less relevant for Ukraine than for any other country. Almost every day we communicate with people who are trying to “lose” extra pounds, we see advertisements for a large number of products designed to reduce body weight. If the attention of the population is focused on the problem of obesity, then mainly on its aesthetic side. And only in recent years have they begun to talk and write that obesity is a disease!

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design